PATENT LICENSE AGREEMENTPatent License Agreement • August 24th, 2018 • Guardant Health, Inc. • Services-medical laboratories • New York
THIS PATENT LICENSE AGREEMENT (the “Agreement”) is made effective as of January 1, 2017 (the “Effective Date”), by and between Keygene N.V. (“KeyGene”), a company organized and existing under the laws of The Netherlands and having its registered offices at Agro Business Park 90, 6708 PW Wageningen, The Netherlands, and Guardant Health, Inc., a company incorporated under the laws of the State of Delaware, and having an address at 505 Penobscot Drive, Redwood City, CA 94063 (“Licensee”) and relates to KeyGene Technology as defined hereinafter. KeyGene and Licensee may be referred to herein individually as a “Party” or collectively as the “Parties.”
ContractJoint Venture Agreement • August 24th, 2018 • Guardant Health, Inc. • Services-medical laboratories • New York
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
AMENDMENT TO SUPPLY AGREEMENTSupply Agreement • August 24th, 2018 • Guardant Health, Inc. • Services-medical laboratories • California
This Amendment to Supply Agreement (the “Amendment”) is made effective as of August 11, 2015 by and between Illumina, Inc., a Delaware corporation having a place of business at 5200 Illumina Way, San Diego, CA 92122 (“Illumina”) and Guardant Health, Inc., having a place of business at 505 Penobscot Drive, Redwood City, CA 94063 (“Customer”). Defined Terms used herein shall follow definitions in the Agreement unless defined herein.
ContractSupply Agreement • August 24th, 2018 • Guardant Health, Inc. • Services-medical laboratories
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
ContractSupply Agreement • August 24th, 2018 • Guardant Health, Inc. • Services-medical laboratories
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
AMENDMENT #4 TO SUPPLY AGREEMENTSupply Agreement • August 24th, 2018 • Guardant Health, Inc. • Services-medical laboratories • California
This Amendment #4 to Supply Agreement (“Amendment #4”) is made effective as of the date of the last signature below (“Amendment #4 Effective Date”) by and between Illumina, Inc., a Delaware corporation having a place of business at 5200 Illumina Way, San Diego, CA 92122 (“Illumina”) and Guardant Health, Inc., having a place of business at 505 Penobscot Drive, Redwood City, CA 94063 (“Customer”). Defined Terms used herein shall follow definitions in the Agreement unless defined herein.
